FDA Inspection 1194602 — Baylor Scott and White McLane Children's Medical Center
The FDA completed an inspection of Baylor Scott and White McLane Children's Medical Center on December 7, 2022 in Temple, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Temple, TX (United States)